{
    "code": "02023963",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023963",
    "time": "2016-12-09 03:04:01",
    "許可證字號": "衛署藥輸字第023963號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/04\/20",
    "發證日期": "93\/04\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202396302",
    "中文品名": "賽達拉敏注射液",
    "英文品名": "DBL CYTARABINE INJECTION",
    "適應症": "抗腫瘤劑。",
    "劑型": "27D注射液劑",
    "包裝": "1公撮、5公撮、10公撮小瓶 、各100支以下小瓶 盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "CYTARABINE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F020031100  HOSPIRA AUSTRALIA PTY LTD.",
        "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008400100",
            "成分名稱": "CYTARABINE",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "P02396302賽達拉敏注射液Cytarabine_CPI(病人用藥資訊)_2015-11版-104-11-12.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023963&Seq=004&Type=9"
        },
        {
            "title": "P02396302賽達拉敏注射液Cytarabine_CPI(靜脈和皮下途徑使用)_2015-11版-104-11-12.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023963&Seq=003&Type=9"
        },
        {
            "title": "P02396301 賽達拉敏注射液Cytarabine-final-104-10-14(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023963&Seq=005&Type=9"
        },
        {
            "title": "P2169501賽達拉敏注射液Cytarabine-final-103-01-07.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023963&Seq=002&Type=9"
        },
        {
            "title": "020239630001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023963&Seq=001&Type=9"
        },
        {
            "title": "P02396302賽達拉敏注射液Cytarabine_外盒及標籤_2015-11版-104-11-12.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023963&Seq=001&Type=8"
        },
        {
            "title": "023963 賽達拉敏注射液(Cytarabine Solution Vail 500mg 5ml-外盒6面-104-10-14(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023963&Seq=002&Type=8"
        }
    ]
}